Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

The crystal structure of human protein farnesyltransferase reveals the basis for inhibition by CaaX tetrapeptides and their mimetics.

Long SB, Hancock PJ, Kral AM, Hellinga HW, Beese LS.

Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):12948-53. Epub 2001 Oct 30.

2.

Advances in the development of farnesyltransferase inhibitors: substrate recognition by protein farnesyltransferase.

Yang W, Del Villar K, Urano J, Mitsuzawa H, Tamanoi F.

J Cell Biochem Suppl. 1997;27:12-9. Review.

PMID:
9591188
3.

Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors.

Schlitzer M.

Curr Pharm Des. 2002;8(19):1713-22. Review.

PMID:
12171543
4.

Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem.

Sousa SF, Fernandes PA, Ramos MJ.

Curr Med Chem. 2008;15(15):1478-92. Review.

PMID:
18537624
5.

Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics.

Cohen LH, Pieterman E, van Leeuwen RE, Overhand M, Burm BE, van der Marel GA, van Boom JH.

Biochem Pharmacol. 2000 Oct 15;60(8):1061-8. Review.

PMID:
11007942
6.

CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agents.

Omer CA, Kohl NE.

Trends Pharmacol Sci. 1997 Nov;18(11):437-44. Review.

PMID:
9426472
7.

Protein farnesyltransferase inhibitors.

Ayral-Kaloustian S, Salaski EJ.

Curr Med Chem. 2002 May;9(10):1003-32. Review.

PMID:
12733981
8.

[Inhibitors of isoprenylation of ras p21].

Yoshimatsu K.

Gan To Kagaku Ryoho. 1997 Sep;24(11):1495-502. Review. Japanese.

PMID:
9309147

Supplemental Content

Support Center